NextGen Healthcare Continues Growth in the California IPA Market

HORSHAM, Pa.--(BUSINESS WIRE)--NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of ambulatory healthcare information systems and connectivity solutions, today announced that Monarch HealthCare, one of California’s largest independent practice associations and medical groups, has selected NextGen Healthcare’s suite of enterprise software solutions to enhance the quality of care its member physicians provide. Products selected for implementation into member practices include NextGen EMR (Electronic Medical Records), NextGen EPM (Enterprise Practice Management), NextGen ICS (Image Control System) and NextGen CHS (Community Health Solution).

“NextGen Healthcare offers innovative, cost-effective solutions that will help us address the challenges of building this network – primarily, our need to integrate this technology with physician partners on a broad scale.”

To date, NextGen enterprise solutions have been selected by California IPAs and California-based medical practices representing over 8,000 health care providers, and a growing number of these providers are benefiting from the use of the technology.

Monarch has more than 2,200 independent physicians in private practices providing care to more than 170,000 Orange County, California residents. In addition to the purchase of NextGen EMR, NextGen EPM and NextGen ICS, the IPA purchased NextGen CHS to facilitate connectivity with their community hospitals, labs and other ambulatory providers in the network. These solutions will be offered to Monarch’s entire physician base.

“Monarch is committed to working collaboratively with our physician partners to create an integrated physician network that enhances the delivery of quality healthcare,” says Bart Asner, M.D., CEO of Monarch HealthCare. “NextGen Healthcare offers innovative, cost-effective solutions that will help us address the challenges of building this network – primarily, our need to integrate this technology with physician partners on a broad scale.”

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), develops and markets computer-based practice management and electronic medical records systems for medical group practices and Healthcare Systems. For more information about NextGen, please visit www.nextgen.com and www.qsii.com.

About Monarch HealthCare

Monarch HealthCare, A Medical Group, Inc, (“Monarch”) is an Independent Practice Association (“IPA”) formed in 1994. It is owned and operated by physicians in the communities it serves. Monarch is among California’s ten largest IPA and Medical Groups and has more than 2,500 independent physicians in private practice providing care to over 170,000 Orange County residents. For more information, please visit www.monarchhealthcare.com.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.